You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 153 No. 12, December 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (5)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Psychiatry
 •Attention Deficit Hyperactivity Disorder
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Difference Between Efficacy and Effectiveness Research in Studying Attention-Deficit/Hyperactivity Disorder

Arch Pediatr Adolesc Med. 1999;153:1220-1221.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

THE STUDY by Zito and colleagues1 in this issue of the ARCHIVES is a welcome first step in understanding the clinical use of stimulant medications in the treatment of attention-deficit/hyperactivity disorder (ADHD). The controversy about treatment with methylphenidate hydrochloride raised in the popular press2-3 continues despite the fact that ADHD and its treatment with stimulant medications and psychosocial interventions have been rigorously studied to a greater degree than any other mental disorder.4-5 The continued concern is the perception that too many children are being treated with stimulant medication.6 The evidence to date suggests that, while there may be inappropriate treatment with methylphenidate as implied by the wide variation in physician and local prescription rates,7 the variations include both undertreatment and overtreatment such that the prevalence of stimulant medication use does not exceed the most commonly accepted prevalence rates for the disorder.8-9 The study by Zito et al further substantiates these . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Psychotherapeutic Medication Patterns for Youths With Attention-Deficit/Hyperactivity Disorder
Julie Magno Zito, Daniel J. Safer, Susan dosReis, Laurence S. Magder, James F. Gardner, and Deborah A. Zarin
Arch Pediatr Adolesc Med. 1999;153(12):1257-1263.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.